Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Development and validation of a clinical rule for recognition of early inflammatory arthritis.

Ten Brinck RM, van Dijk BT, van Steenbergen HW, le Cessie S, Numans ME, Hider SL, Mallen C, van der Helm-van Mil A.

BMJ Open. 2019 Feb 22;8(11):e023552. doi: 10.1136/bmjopen-2018-023552.

2.

Sequence of joint tissue inflammation during rheumatoid arthritis development.

Ten Brinck RM, van Steenbergen HW, van der Helm-van Mil AHM.

Arthritis Res Ther. 2018 Nov 21;20(1):260. doi: 10.1186/s13075-018-1756-z.

3.

Development of clinically apparent synovitis: a longitudinal study at the joint level during progression to inflammatory arthritis.

Ten Brinck RM, van Steenbergen HW, van der Helm-van Mil AHM.

RMD Open. 2018 Sep 7;4(2):e000748. doi: 10.1136/rmdopen-2018-000748. eCollection 2018.

4.

Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.

Boeters DM, Trouw LA, van der Helm-van Mil AHM, van Steenbergen HW.

Arthritis Res Ther. 2018 May 3;20(1):94. doi: 10.1186/s13075-018-1591-2.

5.

Are MRI-detected erosions specific for RA? A large explorative cross-sectional study.

Boeters DM, Nieuwenhuis WP, van Steenbergen HW, Reijnierse M, Landewé RBM, van der Helm-van Mil AHM.

Ann Rheum Dis. 2018 Jun;77(6):861-868. doi: 10.1136/annrheumdis-2017-212252. Epub 2018 Feb 28.

6.

Moderate use of alcohol is associated with lower levels of C reactive protein but not with less severe joint inflammation: a cross-sectional study in early RA and healthy volunteers.

Mangnus L, van Steenbergen HW, Nieuwenhuis WP, Reijnierse M, van der Helm-van Mil AHM.

RMD Open. 2018 Jan 7;4(1):e000577. doi: 10.1136/rmdopen-2017-000577. eCollection 2018.

7.

Preventing progression from arthralgia to arthritis: targeting the right patients.

van Steenbergen HW, da Silva JAP, Huizinga TWJ, van der Helm-van Mil AHM.

Nat Rev Rheumatol. 2018 Jan;14(1):32-41. doi: 10.1038/nrrheum.2017.185. Epub 2017 Nov 9. Review.

8.

The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.

Ten Brinck RM, van Steenbergen HW, van Delft MAM, Verheul MK, Toes REM, Trouw LA, van der Helm-van Mil AHM.

Rheumatology (Oxford). 2017 Dec 1;56(12):2145-2153. doi: 10.1093/rheumatology/kex340.

9.

Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.

Burgers LE, Siljehult F, Ten Brinck RM, van Steenbergen HW, Landewé RBM, Rantapää-Dahlqvist S, van der Helm-van Mil AHM.

Rheumatology (Oxford). 2017 Dec 1;56(12):2123-2128. doi: 10.1093/rheumatology/kex324.

PMID:
28968699
10.

Using a reference when defining an abnormal MRI reduces false-positive MRI results-a longitudinal study in two cohorts at risk for rheumatoid arthritis.

Boer AC, Burgers LE, Mangnus L, Ten Brinck RM, Nieuwenhuis WP, van Steenbergen HW, Reijnierse M, Huizinga TWJ, van der Helm van Mil AHM.

Rheumatology (Oxford). 2017 Oct 1;56(10):1700-1706. doi: 10.1093/rheumatology/kex235.

PMID:
28957551
11.

Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal study.

Ten Brinck RM, van Steenbergen HW, Mangnus L, Burgers LE, Reijnierse M, Huizinga TW, van der Helm-van Mil AH.

RMD Open. 2017 Jun 29;3(1):e000419. doi: 10.1136/rmdopen-2016-000419. eCollection 2017.

12.

Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.

Burgers LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2017 Oct;76(10):1751-1754. doi: 10.1136/annrheumdis-2017-211325. Epub 2017 Jun 12.

PMID:
28606964
13.

Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis.

Mangnus L, van Steenbergen HW, Reijnierse M, Kälvesten J, van der Helm-Van Mil A.

Scand J Rheumatol. 2017 Sep;46(5):364-368. doi: 10.1080/03009742.2017.1299217. Epub 2017 Jun 5.

PMID:
28580826
14.

Evaluation of the diagnostic accuracy of hand and foot MRI for early Rheumatoid Arthritis.

Nieuwenhuis WP, van Steenbergen HW, Mangnus L, Newsum EC, Bloem JL, Huizinga TWJ, le Cessie S, Reijnierse M, van der Helm-van Mil AHM.

Rheumatology (Oxford). 2017 Aug 1;56(8):1367-1377. doi: 10.1093/rheumatology/kex167.

PMID:
28460018
15.

EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.

van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJ, Brouwer E, Codreanu C, Combe B, Fonseca JE, Hetland ML, Humby F, Kvien TK, Niedermann K, Nuño L, Oliver S, Rantapää-Dahlqvist S, Raza K, van Schaardenburg D, Schett G, De Smet L, Szücs G, Vencovský J, Wiland P, de Wit M, Landewé RL, van der Helm-van Mil AH.

Ann Rheum Dis. 2017 Mar;76(3):491-496. doi: 10.1136/annrheumdis-2016-209846. Epub 2016 Oct 6.

PMID:
27991858
16.

Magnetic Resonance Imaging-Detected Features of Inflammation and Erosions in Symptom-Free Persons From the General Population.

Mangnus L, van Steenbergen HW, Reijnierse M, van der Helm-van Mil AH.

Arthritis Rheumatol. 2016 Nov;68(11):2593-2602. doi: 10.1002/art.39749. Epub 2016 Sep 29.

17.

Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons.

Mangnus L, Nieuwenhuis WP, van Steenbergen HW, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Arthritis Res Ther. 2016 Oct 22;18(1):245.

18.

Older age is associated with more MRI-detected inflammation in hand and foot joints.

Nieuwenhuis WP, Mangnus L, van Steenbergen HW, Newsum EC, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Rheumatology (Oxford). 2016 Dec;55(12):2212-2219. Epub 2016 Sep 29.

PMID:
27686099
19.

Magnetic resonance imaging-detected inflammation is associated with functional disability in early arthritis-results of a cross-sectional study.

Burgers LE, Nieuwenhuis WP, van Steenbergen HW, Newsum EC, Huizinga TW, Reijnierse M, le Cessie S, van der Helm-van Mil AH.

Rheumatology (Oxford). 2016 Dec;55(12):2167-2175. Epub 2016 Sep 15.

PMID:
27632997
20.

The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.

Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH.

Ann Rheum Dis. 2017 Jan;76(1):112-118. doi: 10.1136/annrheumdis-2015-208870. Epub 2016 Apr 26.

PMID:
27117699
21.

Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis.

De Winter LM, Hansen WL, van Steenbergen HW, Geusens P, Lenaerts J, Somers K, Stinissen P, van der Helm-van Mil AH, Somers V.

Rheumatology (Oxford). 2016 Aug;55(8):1431-6. doi: 10.1093/rheumatology/kew198. Epub 2016 Apr 19.

PMID:
27094600
22.

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.

PMID:
26757747
23.

How do general practitioners identify inflammatory arthritis? A cohort analysis of Dutch general practitioner electronic medical records.

Newsum EC, de Waal MW, van Steenbergen HW, Gussekloo J, van der Helm-van Mil AH.

Rheumatology (Oxford). 2016 May;55(5):848-53. doi: 10.1093/rheumatology/kev432. Epub 2016 Jan 7.

PMID:
26747844
24.

Clinical expertise and its accuracy in differentiating arthralgia patients at risk for rheumatoid arthritis from other patients presenting with joint symptoms.

van Steenbergen HW, van der Helm-van Mil AH.

Rheumatology (Oxford). 2016 Jun;55(6):1140-1. doi: 10.1093/rheumatology/kev431. Epub 2016 Jan 7. No abstract available.

PMID:
26742783
25.

Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis.

Ajeganova S, Svensson B, Huizinga TW, van der Helm-van Mil AH, van Steenbergen HW.

Ann Rheum Dis. 2016 Apr;75(4):e14. doi: 10.1136/annrheumdis-2015-208954. Epub 2015 Dec 23. No abstract available.

PMID:
26698847
26.

The Course of Bone Marrow Edema in Early Undifferentiated Arthritis and Rheumatoid Arthritis: A Longitudinal Magnetic Resonance Imaging Study at Bone Level.

Nieuwenhuis WP, van Steenbergen HW, Stomp W, Stijnen T, Huizinga TW, Bloem JL, van der Heijde D, Reijnierse M, van der Helm-van Mil AH.

Arthritis Rheumatol. 2016 May;68(5):1080-8. doi: 10.1002/art.39550.

27.

Osteoprotegerin as biomarker for persistence of rheumatoid arthritis.

van Steenbergen HW, van der Helm-van Mil AH.

Rheumatology (Oxford). 2016 May;55(5):949-50. doi: 10.1093/rheumatology/kev415. Epub 2015 Dec 8. No abstract available.

PMID:
26647458
28.

A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort).

Ruyssen-Witrand A, van Steenbergen HW, van Heemst J, Gourraud PA, Nigon D, Lukas C, Miceli-Richard C, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, van der Helm-van Mil AH, Constantin A.

RMD Open. 2015 Nov 19;1(1):e000099. doi: 10.1136/rmdopen-2015-000099. eCollection 2015.

29.

Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.

van Steenbergen HW, Mangnus L, Reijnierse M, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 Oct;75(10):1824-30. doi: 10.1136/annrheumdis-2015-208138. Epub 2015 Nov 27.

PMID:
26613769
30.

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.

Shi J, van Steenbergen HW, van Nies JA, Levarht EW, Huizinga TW, van der Helm-van Mil AH, Toes RE, Trouw LA.

Arthritis Res Ther. 2015 Nov 24;17:339. doi: 10.1186/s13075-015-0860-6.

31.

PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.

Rodriguez-Rodriguez L, Ivorra-Cortes J, Carmona FD, Martín J, Balsa A, van Steenbergen HW, van der Helm-van Mil AH, González-Álvaro I, Fernandez-Gutiérrez B.

Arthritis Res Ther. 2015 Nov 5;17:306. doi: 10.1186/s13075-015-0830-z.

32.

Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study.

van Steenbergen HW, Tsonaka R, Huizinga TW, Boonen A, van der Helm-van Mil AH.

RMD Open. 2015 Mar 4;1(1):e000041. doi: 10.1136/rmdopen-2014-000041. eCollection 2015.

33.

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.

van Heemst J, Trouw LA, Nogueira L, van Steenbergen HW, van der Helm-van Mil AH, Allaart CF, Serre G, Holmdahl R, Huizinga TW, Toes RE, van der Woude D.

Arthritis Res Ther. 2015 Oct 5;17:276. doi: 10.1186/s13075-015-0786-z.

34.

IL2RA is associated with persistence of rheumatoid arthritis.

van Steenbergen HW, van Nies JA, Ruyssen-Witrand A, Huizinga TW, Cantagrel A, Berenbaum F, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Sep 8;17:244. doi: 10.1186/s13075-015-0739-6.

35.

Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis.

Mangnus L, van Steenbergen HW, Lindqvist E, Brouwer E, Reijnierse M, Huizinga TW, Gregersen PK, Berglin E, Rantapää-Dahlqvist S, van der Heijde D, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Aug 24;17:222. doi: 10.1186/s13075-015-0740-0.

36.

Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.

Ajeganova S, van Steenbergen HW, van Nies JA, Burgers LE, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 May;75(5):867-73. doi: 10.1136/annrheumdis-2014-207080. Epub 2015 May 13.

PMID:
25972519
37.

Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey.

Stoof SC, van Steenbergen HW, Zwagemaker A, Sanders YV, Cannegieter SC, Duvekot JJ, Leebeek FW, Peters M, Kruip MJ, Eikenboom J.

Haemophilia. 2015 Jul;21(4):505-12. doi: 10.1111/hae.12635. Epub 2015 Feb 16.

PMID:
25688733
38.

Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.

van Steenbergen HW, Raychaudhuri S, Rodríguez-Rodríguez L, Rantapää-Dahlqvist S, Berglin E, Toes RE, Huizinga TW, Fernández-Gutiérrez B, Gregersen PK, van der Helm-van Mil AH.

Arthritis Rheumatol. 2015 Apr;67(4):877-86. doi: 10.1002/art.39018.

39.

A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.

van Steenbergen HW, Rodríguez-Rodríguez L, Berglin E, Zhernakova A, Knevel R, Ivorra-Cortés J, Huizinga TW, Fernández-Gutiérrez B, Gregersen PK, Rantapää-Dahlqvist S, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Jan 8;17:1. doi: 10.1186/s13075-014-0514-0.

40.

The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.

van Steenbergen HW, Ajeganova S, Forslind K, Svensson B, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 Jan;74(1):e3. doi: 10.1136/annrheumdis-2014-206623. Epub 2014 Oct 6. No abstract available.

PMID:
25288634
41.

Differential methylation within the major histocompatibility complex region in rheumatoid arthritis: a replication study.

van Steenbergen HW, Luijk R, Shoemaker R, Heijmans BT, Huizinga TW, van der Helm-van Mil AH.

Rheumatology (Oxford). 2014 Dec;53(12):2317-8. doi: 10.1093/rheumatology/keu380. Epub 2014 Sep 30. No abstract available.

PMID:
25273994
42.

SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis.

Juge PA, van Steenbergen HW, Constantin A, Tobon GJ, Schaeverbeke T, Gazal S, Combe B, Devauchelle-Pensec V, Nigon D, van der Helm-van Mil AH, Dieude P.

Ann Rheum Dis. 2014 Oct;73(10):1840-3. doi: 10.1136/annrheumdis-2014-205539. Epub 2014 Jun 16.

PMID:
24936586
43.

Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.

van Steenbergen HW, van Nies JA, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Arthritis Res Ther. 2014 Apr 10;16(2):R92. doi: 10.1186/ar4536.

44.

Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI.

van Steenbergen HW, van Nies JA, Huizinga TW, Bloem JL, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 Jun;74(6):1225-32. doi: 10.1136/annrheumdis-2014-205522. Epub 2014 Apr 9.

PMID:
24718962
45.

Does a genetic variant in FOXO3A predict a milder course of rheumatoid arthritis?

van Steenbergen HW, Rantapää-Dahlqvist S, van Nies JA, Berglin E, Huizinga TW, Gregersen PK, van der Helm-van Mil AH.

Arthritis Rheumatol. 2014 Jun;66(6):1678-81. doi: 10.1002/art.38405. No abstract available.

46.

Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis.

van Nies JA, van Steenbergen HW, Krabben A, Stomp W, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 May;74(5):883-9. doi: 10.1136/annrheumdis-2013-204659. Epub 2014 Jan 15.

PMID:
24431393
47.

Predicting the severity of joint damage in rheumatoid arthritis; the contribution of genetic factors.

van Steenbergen HW, Tsonaka R, Huizinga TW, le Cessie S, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 May;74(5):876-82. doi: 10.1136/annrheumdis-2013-204277. Epub 2014 Jan 15.

PMID:
24431388
48.

The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?

van Steenbergen HW, Huizinga TW, van der Helm-van Mil AH.

Arthritis Rheum. 2013 Sep;65(9):2219-32. doi: 10.1002/art.38013. No abstract available.

49.

Anaemia to predict radiographic progression in rheumatoid arthritis.

van Steenbergen HW, van Nies JA, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Jul;72(7):e16. doi: 10.1136/annrheumdis-2013-203718. Epub 2013 Apr 26. No abstract available.

PMID:
23625976

Supplemental Content

Loading ...
Support Center